IRB Committee 2 is responsible for the full review of human subjects research protocols for the C.T. Bauer School of Business, the College of the Arts, and the College of Liberal Arts and Social Sciences (CLASS), with the exception of the Department of Health and Human Performance. IRB 2 does not review FDA-regulated research.
|Submission Deadlines||IRB 2 Meeting Date|
|Friday, August 11, 2017||Friday, August 25, 2017|
|Friday, September 8, 2017||Friday, September 22, 2017|
|Friday, October 13, 2017||Friday, October 27, 2017|
|Friday, November 3, 2017||Friday, November 17, 2017|
|Wednesday, November 22, 2017||Friday, December 8, 2017|
|Friday, January 12, 2018||Friday, January 26, 2018|
|Friday, February 9, 2018||Friday, February 23, 2018|
|Thursday, March 15, 2018||Friday, March 30, 2018|
|Friday, April 13, 2018||Friday, April 27, 2018|
|Friday, May 11, 2018||Friday, May 25, 2018|
|Friday, June 8, 2018||Friday, June 22, 2018|
|Friday, July 13, 2018||Friday, July 27, 2018|
|Friday, August 10, 2018||Friday, August 24, 2018|
*Dates are subject to change without notice if circumstances require rescheduling.
Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 2 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approves or requires modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.
Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.